News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Trencher Daniel
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/18/2023 |
4
| Trencher Daniel (CHIEF STRATEGY OFFICER) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $22.81, valued at
$22.8k
|
|
08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/18/2023 |
4
| Trencher Daniel (CHIEF STRATEGY OFFICER) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $24.66, valued at
$24.7k
|
|
07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/18/2023 |
4
| Trencher Daniel (CHIEF STRATEGY OFFICER) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $23.81, valued at
$23.8k
|
|
05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/20/2023 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $25.13, valued at
$25.1k
|
|
03/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/07/2023 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,838 shares
@ $25.911, valued at
$47.6k
Granted 33,482 restricted stock units
@ $0 |
|
01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $26.93, valued at
$26.9k
|
|
11/18/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $30.14, valued at
$30.1k
|
|
10/18/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $24.04, valued at
$24k
|
|
09/20/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $30.18, valued at
$30.2k
|
|
08/18/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $37.5, valued at
$37.5k
|
|
07/19/2022 |
4
| Trencher Daniel (SVP CORPORATE STRATEGY) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 1,000 shares
@ $41.12, valued at
$41.1k
|
|
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2022 |
4
| Trencher Daniel (SVP Corporate Strategy) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 2,000 shares
@ $81.75, valued at
$163.5k
Exercised 2,000 options to buy
@ $22.3, valued at
$44.6k
|
|
12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2021 |
4
| Trencher Daniel (SVP Corporate Strategy) has filed a Form 4 on Teladoc Health, Inc.
Txns:
| Sold 2,000 shares
@ $140.18, valued at
$280.4k
Exercised 2,000 options to buy
@ $22.3, valued at
$44.6k
|
|
10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|